Shirley Chu

Dr. Shirley Chu

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Veterinary Microbiology
Verified
Journal Article
Closed access
SCShirley Chu
Shirley Chu
TWTodd N. Wylie
Todd N. Wylie
KWKristine M. Wylie
Kristine M. Wylie
GJGayle C. Johnson
Gayle C. Johnson
ZSZachary L. Skidmore
Zachary L. Skidmore
JBJeffrey N. Bryan
Jeffrey N. Bryan

8 February 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SCShirley Chu
Shirley Chu
ZSZachary L. Skidmore
Zachary L. Skidmore
JKJason Kunisaki
Jason Kunisaki
JWJason R. Walker
Jason R. Walker
MGMalachi Griffith
Malachi Griffith
JBJeffrey N. Bryan
Jeffrey N. Bryan
Osteosarcoma is a rare disease in children but is one of the most common cancers in adult large breed dogs. The mutational landscape of both the primary and pulmonary metastatic tumor in two dogs with appendicular osteosarcoma (OSA) was comprehensively evaluated using an automated whole genome sequencing, exome and RNA-seq pipeline that was adapted for this study for use in dogs. Chromosomal lesions were the most common type of mutation. The mutational landscape varied substantially between dogs but the lesions within the same patient were similar. Copy number neutral loss of heterozygosity in mutantTP53was the most significant driver mutation and involved a large region in the middle of chromosome 5. Canine and human OSA is characterized by loss of cell cycle checkpoint integrity and DNA damage response pathways. Mutational profiling of individual patients with canine OSA would be recommended prior to targeted therapy, given the heterogeneity seen in our study and previous studies.

27 May 2023 in Veterinary and Comparative Oncology
Verified
Journal Article
Closed access
LNLucie Noall
Lucie Noall
SLSuhwon Lee
Suhwon Lee
JBJenna H. Burton
Jenna H. Burton
TMTaya M. Marquardt
Taya M. Marquardt
JCJustin Cermak
Justin Cermak
SCShirley Chu
Shirley Chu

17 July 2024 in Veterinary and Comparative Oncology
Verified
Journal Article
Closed access
KKKei Kuroki
Kei Kuroki
CHChristine Tran Hoang
Christine Tran Hoang
ARAnita M. Rogic
Anita M. Rogic
HRHans Rindt
Hans Rindt
ASAngelynn Simenson
Angelynn Simenson
SCShirley Chu
Shirley Chu

31 July 2022 in Epigenetics
Verified
Journal Article
Closed access
SCShirley Chu
Shirley Chu
AAAnne Avery
Anne Avery
JYJanna Yoshimoto
Janna Yoshimoto
JBJeffrey N. Bryan
Jeffrey N. Bryan
Few recurrent DNA mutations are seen in aggressive canine B cell lymphomas (cBCL), suggesting other frequent drivers. The methylated island recovery assay (MIRA-seq) or methylated CpG-binding domain sequencing (MBD-seq) was used to define the genome-wide methylation profiles in aggressive cBCL in Golden Retrievers to determine if cBCL can be better defined by epigenetic changes than by DNA mutations. DNA hypermethylation patterns were relatively homogenous within cBCL samples in Golden Retrievers, in different breeds and in geographical regions. Aberrant hypermethylation is thus suspected to be a central and early event in cBCL lymphomagenesis. Distinct subgroups within cBCL in Golden Retrievers were not identified with DNA methylation profiles. In comparison, the methylome profile of human DLBCL (hDLBCL) is relatively heterogeneous. Only moderate similarity between hDLBCL and cBCL was seen and cBCL likely cannot be accurately classified into the subtypes seen in hDLBCL. Genes with hypermethylated regions in the promoter-TSS-first exon of cBCL compared to normal B cells often also had additional hyper- and hypomethylated regions distributed throughout the gene suggesting non-randomized repeat targeting of key genes by epigenetic mechanisms. The prevalence of hypermethylation in transcription factor families in aggressive cBCL may represent a fundamental step in lymphomagenesis.

28 April 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
ESElizabeth Schaefer
Elizabeth Schaefer
SCShirley Chu
Shirley Chu
KWKristine Wylie
Kristine Wylie
TWTodd Wylie
Todd Wylie
OGObi L. Griffith
Obi L. Griffith
BFBrian K. Flesner
Brian K. Flesner
Our study aims are: (1) to evaluate phenotypically normal canine conjunctival and orbital tissue and tissue from canine lobular orbital adenomas (CLOAs) for the presence of viral genomic material and (2) phylogenetically classify detected DNA viruses to determine if a DNA virus is associated with CLOAs. A total of 31 formalin fixed paraffin embedded CLOA tissue samples, 4 papillomas or sarcoid, and 10 fresh clinically normal conjunctival tissues were included in this study. Genomic DNA was isolated from all samples and sequencing libraries were prepared. The libraries were molecularly indexed and pooled and viral DNA was enriched via targeted sequence capture utilizing ViroCap. The libraries were sequenced on the Illumina HiSeq platform and compared to known viral DNA reference genomes to identify viral DNA. Carnivore parvovirus was identified in 6.4% and 20% of CLOA tissue and normal conjunctival samples, respectively. This study showed that conjunctival tissue from healthy dogs and CLOAs uncommonly harbor DNA viruses, and no DNA virus was associated with these tumors. Further studies are needed to evaluate the etiologic cause of CLOAs.